Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 02 Oct 2026 for Oramed Pharmaceuticals INC., €80k. Read the official filing
Filing timeline
BuySaleAvraham Gabay
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
No signal scores available.
Avraham Gabay: trading record in brief
Avraham Gabay has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Oramed Pharmaceuticals Inc. and Lifeward Ltd. In total, 10 filings cover trades dated from 21 June 2024 to 1 October 2026.
Every open-market trade on record is a sale: 1 sale worth €80k. The rest of the record consists of 8 share grants and 1 option exercise. Since January 2026: no purchases and 1 sale on the market.
On 2 October 2026 came the latest disclosure, an open-market sale for €80k in Oramed Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Avraham Gabay
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
20,000 shares@ US$4.51Common StockSEC:0001213900-26-106531:0
209,291 sharesCommon StockSEC:0001213900-26-103535:0
13,643 shares0Ordinary Shares, no par value per shareSEC:0001178913-26-004241:0
95,889 shares0Common StockSEC:0001213900-26-031011:0
19,000 shares0Common StockSEC:0001213900-26-009476:0
81,216 shares0Common StockSEC:0001213900-26-000658:0
34,000 shares0Common StockSEC:0001213900-25-012238:0
188,000 sharesCommon StockSEC:0001213900-25-001166:0
30,000 sharesCommon StockSEC:0001213900-24-095932:0
140,040 sharesCommon StockSEC:0001213900-24-054781:0
10 of 10 declarations
